Free Trial

Afya (AFYA) Financials

Afya logo
$19.12 -0.26 (-1.34%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$19.11 -0.01 (-0.03%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Afya

Annual Income Statements for Afya

This table shows Afya's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
14 22 -59 56 84 71 80 102
Consolidated Net Income / (Loss)
15 24 43 59 43 74 84 105
Net Income / (Loss) Continuing Operations
15 24 -59 59 43 74 84 105
Total Pre-Tax Income
15 25 -59 65 49 81 89 109
Total Operating Income
15 25 -59 70 79 126 158 164
Total Gross Profit
28 43 110 148 191 278 364 338
Total Revenue
65 86 0.65 231 308 441 593 534
Operating Revenue
65 86 0.65 231 308 441 593 534
Total Cost of Revenue
37 43 0.00 84 117 163 229 197
Operating Cost of Revenue
37 43 - 84 117 163 229 197
Total Operating Expenses
14 18 59 78 112 152 206 174
Selling, General & Admin Expense
14 18 59 78 112 151 209 173
Other Operating Expenses / (Income)
- -0.15 - 0.07 0.64 1.37 -3.22 1.18
Total Other Income / (Expense), net
0.49 0.59 0.00 -6.93 -32 -47 -72 -56
Interest Expense
1.08 2.10 - 19 44 66 94 74
Interest & Investment Income
1.58 2.69 - 12 12 19 23 18
Other Income / (Expense), net
0.83 0.00 - 1.48 2.12 2.30 1.96 1.90
Income Tax Expense
0.75 1.03 - 5.21 5.59 6.75 4.98 4.44
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.93 -2.16 - -3.06 -3.40 -3.63 -3.93 -2.82
Basic Earnings per Share
$1.41 $1.84 - $3.15 $2.39 $4.14 $4.30 $1.13
Weighted Average Basic Shares Outstanding
- - 0.00 93.15M 92.07M 93.72M 93.72M 93.72M
Diluted Earnings per Share
$1.41 $1.81 - $3.12 $2.37 $4.12 $4.27 $1.12
Weighted Average Diluted Shares Outstanding
- - 0.00 93.15M 92.07M 93.72M 93.72M 93.72M
Weighted Average Basic & Diluted Shares Outstanding
- - 0.00 93.15M 92.07M 93.72M 93.72M 93.72M

Quarterly Income Statements for Afya

No quarterly income statements for Afya are available.


Annual Cash Flow Statements for Afya

This table details how cash moves in and out of Afya's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
0.33 0.22 219 20 220 136 -89 101
Net Cash From Operating Activities
0.67 1.89 296 64 103 64 -31 71
Net Cash From Continuing Operating Activities
0.67 1.89 296 64 103 64 -31 71
Net Income / (Loss) Continuing Operations
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation Expense
1.21 2.34 - - 28 39 60 54
Non-Cash Adjustments To Reconcile Net Income
-0.34 -0.43 296 64 76 26 -87 15
Changes in Operating Assets and Liabilities, net
-0.21 -0.02 - - -0.42 -0.42 -3.16 2.93
Net Cash From Investing Activities
0.00 0.00 -74 -194 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
0.00 0.00 -74 -194 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
-0.34 -1.67 -30 159 117 72 -58 30
Net Cash From Continuing Financing Activities
-0.34 -1.67 -30 159 117 72 -58 30
Repayment of Debt
- - -19 -30 -19 -0.34 -23 -21
Issuance of Debt
0.00 - 1.84 116 145 94 1.09 79
Other Financing Activities, net
-0.34 -1.67 - - -9.02 -22 -36 -29

Quarterly Cash Flow Statements for Afya

No quarterly cash flow statements for Afya are available.


Annual Balance Sheets for Afya

This table presents Afya's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
237 725 923 1,157 1,362 1,563 1,428
Total Current Assets
34 277 271 216 310 248 257
Cash & Equivalents
16 235 201 134 207 114 147
Accounts Receivable
15 31 58 68 86 113 96
Current Deferred & Refundable Income Taxes
0.58 1.61 4.05 4.59 5.26 9.02 4.16
Other Current Assets
2.28 4.46 5.70 7.63 9.79 12 9.24
Plant, Property, & Equipment, net
17 35 50 75 103 125 106
Plant, Property & Equipment, gross
17 35 50 75 103 125 106
Total Noncurrent Assets
185 413 537 860 942 1,182 1,058
Long-Term Investments
0.00 11 9.90 8.70 10 11 8.80
Intangible Assets
176 327 495 700 765 988 895
Other Noncurrent Operating Assets
8.11 73 31 151 167 182 155
Total Liabilities & Shareholders' Equity
237 725 923 1,157 1,362 1,563 1,428
Total Liabilities
85 199 377 618 747 812 731
Total Current Liabilities
47 83 113 137 125 218 184
Short-Term Debt
6.91 13 21 23 27 37 59
Accounts Payable
2.09 4.39 43 11 63 22 51
Customer Deposits
3.54 9.17 12 21 25 32 26
Current Deferred & Payable Income Tax Liabilities
0.07 0.80 0.88 2.09 3.06 0.80 0.69
Current Employee Benefit Liabilities
8.24 - 15 24 - 40 34
Other Current Liabilities
23 39 13 50 6.65 81 9.12
Total Noncurrent Liabilities
38 116 264 481 570 594 546
Long-Term Debt
13 1.68 98 237 340 334 296
Capital Lease Obligations
0.00 65 74 124 139 173 151
Other Noncurrent Operating Liabilities
23 42 0.74 79 53 48 63
Total Equity & Noncontrolling Interests
152 526 546 538 673 751 697
Total Preferred & Common Equity
129 514 536 529 663 742 690
Total Common Equity
114 514 536 529 663 742 690
Common Stock
113 480 447 426 449 487 379
Retained Earnings
- 29 79 113 190 284 325
Treasury Stock
- - 0.00 -27 - -62 -44
Other Equity Adjustments
0.56 4.51 9.77 17 23 32 30
Noncontrolling Interest
23 12 9.93 9.30 9.71 8.55 6.57

Quarterly Balance Sheets for Afya

No quarterly balance sheets for Afya are available.


Annual Metrics and Ratios for Afya

This table displays calculated financial ratios and metrics derived from Afya's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 31.95% -99.25% 35,729.12% 33.37% 42.86% 34.52% -9.85%
EBITDA Growth
0.00% 60.49% -316.41% 221.37% 52.41% 53.36% 31.60% -0.11%
EBIT Growth
0.00% 58.02% -336.78% 221.37% 13.68% 57.56% 25.10% 3.45%
NOPAT Growth
0.00% 68.35% -272.72% 256.08% 8.97% 64.37% 29.54% 5.24%
Net Income Growth
0.00% 66.79% 76.08% 37.94% -26.70% 70.97% 12.45% 25.59%
EPS Growth
0.00% 28.37% 0.00% 0.00% -24.04% 73.84% 3.64% 27.34%
Operating Cash Flow Growth
0.00% 181.76% 15,566.45% -78.51% 62.11% -37.85% -147.60% 333.90%
Free Cash Flow Firm Growth
0.00% 0.00% -93.29% 53.91% -59.48% 93.94% -840.81% 358.05%
Invested Capital Growth
0.00% 0.00% 138.15% 48.83% 46.54% 15.42% 27.21% -10.29%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - -
Gross Margin
42.56% 49.68% 17,030.73% 63.81% 62.06% 63.09% 61.41% 63.21%
EBITDA Margin
25.98% 31.60% -9,118.20% 30.89% 35.30% 37.89% 37.07% 41.07%
Operating Margin
22.84% 28.88% -9,118.20% 30.25% 25.64% 28.51% 26.67% 30.63%
EBIT Margin
24.12% 28.88% -9,118.20% 30.89% 26.33% 29.04% 27.00% 30.99%
Profit (Net Income) Margin
22.44% 28.37% 6,660.06% 25.64% 14.09% 16.86% 14.10% 19.64%
Tax Burden Percent
95.10% 95.96% -73.04% 91.92% 88.60% 91.67% 94.37% 95.94%
Interest Burden Percent
97.85% 102.36% 100.00% 90.30% 60.41% 63.35% 55.32% 66.06%
Effective Tax Rate
4.90% 4.04% 0.00% 8.08% 11.40% 8.33% 5.63% 4.06%
Return on Invested Capital (ROIC)
0.00% 30.13% -15.39% 13.71% 10.13% 13.00% 13.84% 13.71%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 48.34% -133.35% 21.21% -7.63% -1.58% -4.08% 1.34%
Return on Net Nonoperating Assets (RNNOA)
0.00% 1.96% 28.07% -2.64% -2.11% -0.73% -2.10% 0.78%
Return on Equity (ROE)
0.00% 32.09% 12.68% 11.07% 8.02% 12.27% 11.74% 14.50%
Cash Return on Invested Capital (CROIC)
0.00% -169.87% -97.10% -25.54% -27.62% -1.31% -10.11% 24.57%
Operating Return on Assets (OROA)
0.00% 10.50% -12.24% 8.67% 7.81% 10.16% 10.94% 11.07%
Return on Assets (ROA)
0.00% 10.31% 8.94% 7.20% 4.18% 5.90% 5.71% 7.02%
Return on Common Equity (ROCE)
0.00% 24.04% 11.74% 10.84% 7.88% 12.08% 11.59% 14.34%
Return on Equity Simple (ROE_SIMPLE)
0.00% 18.87% 8.37% 11.07% 8.22% 11.21% 11.26% 15.20%
Net Operating Profit after Tax (NOPAT)
14 24 -41 64 70 115 149 157
NOPAT Margin
21.72% 27.72% -6,382.74% 27.80% 22.72% 26.14% 25.17% 29.39%
Net Nonoperating Expense Percent (NNEP)
0.00% -18.21% 117.96% -7.51% 17.76% 14.58% 17.91% 12.37%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 13.05%
Cost of Revenue to Revenue
57.44% 50.32% 0.00% 36.19% 37.94% 36.91% 38.59% 36.79%
SG&A Expenses to Revenue
21.00% 20.97% 9,218.20% 33.54% 36.21% 34.27% 35.28% 32.36%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.00% 20.79% 9,218.20% 33.57% 36.42% 34.58% 34.74% 32.58%
Earnings before Interest and Taxes (EBIT)
16 25 -59 71 81 128 160 166
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
17 27 -59 71 109 167 220 219
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 2.29 0.73 0.00 2.77 2.17 2.77 2.13
Price to Tangible Book Value (P/TBV)
0.00 0.00 1.99 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
4.00 3.03 577.51 0.00 4.74 3.26 3.47 2.75
Price to Earnings (P/E)
19.05 11.73 0.00 0.00 17.52 20.35 25.81 14.39
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.25% 8.52% 0.00% 0.00% 5.71% 4.91% 3.87% 6.95%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.82 0.57 0.00 2.08 1.83 2.06 1.69
Enterprise Value to Revenue (EV/Rev)
0.00 3.34 333.55 0.00 5.55 3.95 4.19 3.42
Enterprise Value to EBITDA (EV/EBITDA)
0.00 10.58 0.00 0.00 15.73 10.41 11.30 8.32
Enterprise Value to EBIT (EV/EBIT)
0.00 11.58 0.00 0.00 21.09 13.59 15.51 11.03
Enterprise Value to NOPAT (EV/NOPAT)
0.00 12.07 0.00 0.00 24.45 15.09 16.64 11.63
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 152.24 0.73 0.00 16.61 27.11 0.00 25.58
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.49
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 0.13 0.15 0.35 0.71 0.75 0.72 0.73
Long-Term Debt to Equity
0.00 0.09 0.13 0.32 0.67 0.71 0.68 0.64
Financial Leverage
0.00 0.04 -0.21 -0.12 0.28 0.46 0.51 0.58
Leverage Ratio
0.00 1.56 1.42 1.54 1.92 2.08 2.06 2.07
Compound Leverage Factor
0.00 1.59 1.42 1.39 1.16 1.32 1.14 1.36
Debt to Total Capital
0.00% 11.65% 13.23% 26.15% 41.60% 43.00% 42.00% 42.05%
Short-Term Debt to Total Capital
0.00% 4.01% 2.20% 2.79% 2.51% 2.33% 2.85% 4.89%
Long-Term Debt to Total Capital
0.00% 7.64% 11.03% 23.35% 39.09% 40.67% 39.15% 37.16%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 13.23% 2.00% 1.34% 1.01% 0.82% 0.66% 0.55%
Common Equity to Total Capital
0.00% 66.18% 84.78% 72.51% 57.39% 56.18% 57.34% 57.40%
Debt to EBITDA
0.00 0.74 -1.36 2.70 3.52 3.04 2.47 2.30
Net Debt to EBITDA
0.00 0.14 2.88 -0.26 2.21 1.74 1.91 1.59
Long-Term Debt to EBITDA
0.00 0.48 -1.14 2.42 3.31 2.87 2.31 2.04
Debt to NOPAT
0.00 0.84 -1.95 3.00 5.47 4.41 3.64 3.22
Net Debt to NOPAT
0.00 0.16 4.12 -0.29 3.43 2.52 2.81 2.23
Long-Term Debt to NOPAT
0.00 0.55 -1.62 2.68 5.14 4.17 3.40 2.85
Altman Z-Score
0.00 2.50 1.23 0.00 2.14 2.15 2.51 2.34
Noncontrolling Interest Sharing Ratio
0.00% 25.10% 7.42% 2.06% 1.77% 1.57% 1.28% 1.04%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 0.73 3.34 2.38 1.57 2.47 1.14 1.39
Quick Ratio
0.00 0.67 3.21 2.29 1.47 2.33 1.04 1.32
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -134 -260 -120 -191 -12 -109 281
Operating Cash Flow to CapEx
0.00% 0.00% 2,089.35% 367.92% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -63.99 0.00 -6.33 -4.37 -0.18 -1.16 3.79
Operating Cash Flow to Interest Expense
0.62 0.90 0.00 3.36 2.36 0.97 -0.32 0.96
Operating Cash Flow Less CapEx to Interest Expense
0.62 0.90 0.00 2.45 2.36 0.97 -0.32 0.96
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.36 0.00 0.28 0.30 0.35 0.41 0.36
Accounts Receivable Turnover
0.00 5.71 0.03 5.17 4.89 5.74 5.98 5.11
Inventory Turnover
0.00 150.72 0.00 69.04 65.60 73.45 176.56 0.00
Fixed Asset Turnover
0.00 5.08 0.03 5.45 4.92 4.95 5.20 4.61
Accounts Payable Turnover
0.00 20.74 0.00 3.52 4.35 4.42 5.36 2.69
Days Sales Outstanding (DSO)
0.00 63.88 13,083.97 70.56 74.60 63.59 61.05 71.38
Days Inventory Outstanding (DIO)
0.00 2.42 0.00 5.29 5.56 4.97 2.07 0.00
Days Payable Outstanding (DPO)
0.00 17.60 0.00 103.69 83.85 82.64 68.09 135.49
Cash Conversion Cycle (CCC)
0.00 48.70 13,083.97 -27.84 -3.68 -14.08 -4.97 -64.12
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 158 377 561 822 949 1,207 1,083
Invested Capital Turnover
0.00 1.09 0.00 0.49 0.45 0.50 0.55 0.47
Increase / (Decrease) in Invested Capital
0.00 158 219 184 261 127 258 -124
Enterprise Value (EV)
0.00 288 215 0.00 1,713 1,738 2,483 1,825
Market Capitalization
261 261 373 0.00 1,463 1,438 2,055 1,469
Book Value per Share
$0.00 $8.29 $37.39 $5.75 $5.68 $7.20 $7.92 $7.37
Tangible Book Value per Share
$0.00 ($4.51) $13.63 $0.43 ($1.83) ($1.10) ($2.63) ($2.18)
Total Capital
0.00 172 606 739 921 1,180 1,295 1,203
Total Debt
0.00 20 80 193 383 507 544 506
Total Long-Term Debt
0.00 13 67 173 360 480 507 447
Net Debt
0.00 3.87 -170 -18 240 290 419 350
Capital Expenditures (CapEx)
0.00 0.00 14 17 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -22 -31 -24 -32 5.11 -47 -16
Debt-free Net Working Capital (DFNWC)
0.00 -5.68 207 178 102 212 67 131
Net Working Capital (NWC)
0.00 -13 194 157 79 184 30 73
Net Nonoperating Expense (NNE)
-0.47 -0.56 -84 5.00 27 41 66 52
Net Nonoperating Obligations (NNO)
0.00 6.18 -149 16 284 276 456 386
Total Depreciation and Amortization (D&A)
1.21 2.34 0.00 0.00 28 39 60 54
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -25.41% -4,851.74% -10.31% -10.44% 1.16% -7.96% -2.96%
Debt-free Net Working Capital to Revenue
0.00% -6.60% 32,079.54% 76.86% 33.10% 48.09% 11.27% 24.61%
Net Working Capital to Revenue
0.00% -14.62% 30,012.96% 67.94% 25.61% 41.86% 5.04% 13.61%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $2.03 $3.15 $0.00 $4.14 $4.30 $1.13
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 93.15M 92.07M 93.72M 93.72M 93.72M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $2.02 $3.12 $0.00 $4.12 $4.27 $1.12
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 93.15M 92.07M 93.72M 93.72M 93.72M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 93.15M 92.07M 93.72M 93.72M 93.72M
Normalized Net Operating Profit after Tax (NOPAT)
14 24 -41 64 70 115 149 157
Normalized NOPAT Margin
21.72% 27.72% -6,382.74% 27.80% 22.72% 26.14% 25.17% 29.39%
Pre Tax Income Margin
23.60% 29.56% -9,118.20% 27.89% 15.90% 18.40% 14.94% 20.47%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
14.53 11.83 0.00 3.78 1.86 1.93 1.70 2.23
NOPAT to Interest Expense
13.09 11.35 0.00 3.40 1.60 1.74 1.58 2.12
EBIT Less CapEx to Interest Expense
14.53 11.83 0.00 2.86 1.86 1.93 1.70 2.23
NOPAT Less CapEx to Interest Expense
13.09 11.35 0.00 2.48 1.60 1.74 1.58 2.12
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 29.99% 4.22% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 29.99% 4.22% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Afya

No quarterly metrics and ratios for Afya are available.


Frequently Asked Questions About Afya's Financials

When does Afya's fiscal year end?

According to the most recent income statement we have on file, Afya's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Afya's net income changed over the last 7 years?

Afya's net income appears to be on an upward trend, with a most recent value of $104.94 million in 2024, rising from $14.64 million in 2017. The previous period was $83.55 million in 2023. View Afya's forecast to see where analysts expect Afya to go next.

What is Afya's operating income?
Afya's total operating income in 2024 was $163.67 million, based on the following breakdown:
  • Total Gross Profit: $337.76 million
  • Total Operating Expenses: $174.10 million
How has Afya revenue changed over the last 7 years?

Over the last 7 years, Afya's total revenue changed from $65.22 million in 2017 to $534.34 million in 2024, a change of 719.3%.

How much debt does Afya have?

Afya's total liabilities were at $730.75 million at the end of 2024, a 10.0% decrease from 2023, and a 764.3% increase since 2018.

How much cash does Afya have?

In the past 6 years, Afya's cash and equivalents has ranged from $16.04 million in 2018 to $234.69 million in 2019, and is currently $147.32 million as of their latest financial filing in 2024.

How has Afya's book value per share changed over the last 7 years?

Over the last 7 years, Afya's book value per share changed from 0.00 in 2017 to 7.37 in 2024, a change of 736.7%.



This page (NASDAQ:AFYA) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners